177 related articles for article (PubMed ID: 28219935)
21. Human ZNF312b oncogene is regulated by Sp1 binding to its promoter region through DNA demethylation and histone acetylation in gastric cancer.
Song IS; Ha GH; Kim JM; Jeong SY; Lee HC; Kim YS; Kim YJ; Kwon TK; Kim NS
Int J Cancer; 2011 Nov; 129(9):2124-33. PubMed ID: 21170990
[TBL] [Abstract][Full Text] [Related]
22. Lgr5 expression as stem cell marker in human gastric gland and its relatedness with other putative cancer stem cell markers.
Wu C; Xie Y; Gao F; Wang Y; Guo Y; Tian H; Li Y; Fan W
Gene; 2013 Aug; 525(1):18-25. PubMed ID: 23664892
[TBL] [Abstract][Full Text] [Related]
23. Inactivation of BLU is associated with methylation of Sp1-binding site of BLU promoter in gastric cancer.
Xiao K; Yu Z; Shi DT; Lei Z; Chen H; Cao J; Tian W; Chen W; Zhang HT
Int J Oncol; 2015 Aug; 47(2):621-31. PubMed ID: 26043875
[TBL] [Abstract][Full Text] [Related]
24. RSPO2-LGR5 signaling has tumour-suppressive activity in colorectal cancer.
Wu C; Qiu S; Lu L; Zou J; Li WF; Wang O; Zhao H; Wang H; Tang J; Chen L; Xu T; Sun Z; Liao W; Luo G; Lu X
Nat Commun; 2014; 5():3149. PubMed ID: 24476626
[TBL] [Abstract][Full Text] [Related]
25. Clinical value of R-spondins in triple-negative and metaplastic breast cancers.
Coussy F; Lallemand F; Vacher S; Schnitzler A; Chemlali W; Caly M; Nicolas A; Richon S; Meseure D; El Botty R; De-Plater L; Fuhrmann L; Dubois T; Roman-Roman S; Dangles-Marie V; Marangoni E; Bièche I
Br J Cancer; 2017 Jun; 116(12):1595-1603. PubMed ID: 28472820
[TBL] [Abstract][Full Text] [Related]
26. LGR5 is associated with tumor aggressiveness in papillary thyroid cancer.
Michelotti G; Jiang X; Sosa JA; Diehl AM; Henderson BB
Oncotarget; 2015 Oct; 6(33):34549-60. PubMed ID: 26416247
[TBL] [Abstract][Full Text] [Related]
27. R-spondins can potentiate WNT signaling without LGRs.
Lebensohn AM; Rohatgi R
Elife; 2018 Feb; 7():. PubMed ID: 29405118
[TBL] [Abstract][Full Text] [Related]
28. Engineering high-potency R-spondin adult stem cell growth factors.
Warner ML; Bell T; Pioszak AA
Mol Pharmacol; 2015; 87(3):410-20. PubMed ID: 25504990
[TBL] [Abstract][Full Text] [Related]
29. Distribution of Lgr5-positive cancer cells in intramucosal gastric signet-ring cell carcinoma.
Nakajima T; Uehara T; Maruyama Y; Iwaya M; Kobayashi Y; Ota H
Pathol Int; 2016 Sep; 66(9):518-23. PubMed ID: 27593551
[TBL] [Abstract][Full Text] [Related]
30. The structural basis of R-spondin recognition by LGR5 and RNF43.
Chen PH; Chen X; Lin Z; Fang D; He X
Genes Dev; 2013 Jun; 27(12):1345-50. PubMed ID: 23756651
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of TNFα-interacting protein α (Tipα)-associated gastric carcinogenesis by BTG2
Devanand P; Oya Y; Sundaramoorthy S; Song KY; Watanabe T; Kobayashi Y; Shimizu Y; Hong SA; Suganuma M; Lim IK
Exp Mol Med; 2018 Feb; 50(2):e449. PubMed ID: 29472702
[TBL] [Abstract][Full Text] [Related]
32. Structural basis for R-spondin recognition by LGR4/5/6 receptors.
Wang D; Huang B; Zhang S; Yu X; Wu W; Wang X
Genes Dev; 2013 Jun; 27(12):1339-44. PubMed ID: 23756652
[TBL] [Abstract][Full Text] [Related]
33. The role of R-spondin proteins in cancer biology.
Ter Steege EJ; Bakker ERM
Oncogene; 2021 Nov; 40(47):6469-6478. PubMed ID: 34663878
[TBL] [Abstract][Full Text] [Related]
34. Depletion of death-associated protein-3 induces chemoresistance in gastric cancer cells through the β-catenin/LGR5/Bcl-2 axis.
Jia Y; Li Z; Cheng X; Wu X; Pang F; Shi J; Li S; Li X; Hu Y; Zhang L; Ji J
J Investig Med; 2019 Jun; 67(5):856-861. PubMed ID: 30792218
[TBL] [Abstract][Full Text] [Related]
35. The spatial distribution of LGR5+ cells correlates with gastric cancer progression.
Simon E; Petke D; Böger C; Behrens HM; Warneke V; Ebert M; Röcken C
PLoS One; 2012; 7(4):e35486. PubMed ID: 22530031
[TBL] [Abstract][Full Text] [Related]
36. R-spondin-3 induces secretory, antimicrobial Lgr5
Sigal M; Reinés MDM; Müllerke S; Fischer C; Kapalczynska M; Berger H; Bakker ERM; Mollenkopf HJ; Rothenberg ME; Wiedenmann B; Sauer S; Meyer TF
Nat Cell Biol; 2019 Jul; 21(7):812-823. PubMed ID: 31235935
[TBL] [Abstract][Full Text] [Related]
37. Gastric Lgr5(+) stem cells are the cellular origin of invasive intestinal-type gastric cancer in mice.
Li XB; Yang G; Zhu L; Tang YL; Zhang C; Ju Z; Yang X; Teng Y
Cell Res; 2016 Jul; 26(7):838-49. PubMed ID: 27091432
[TBL] [Abstract][Full Text] [Related]
38. LGR5 expression is associated with prognosis in poorly differentiated gastric adenocarcinoma.
Ehara T; Uehara T; Nakajima T; Kinugawa Y; Kobayashi S; Iwaya M; Ota H; Soejima Y
BMC Cancer; 2021 Mar; 21(1):228. PubMed ID: 33676447
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of Rspo-Lgr4 Facilitates Checkpoint Blockade Therapy by Switching Macrophage Polarization.
Tan B; Shi X; Zhang J; Qin J; Zhang N; Ren H; Qian M; Siwko S; Carmon K; Liu Q; Han H; Du B; Liu M
Cancer Res; 2018 Sep; 78(17):4929-4942. PubMed ID: 29967265
[TBL] [Abstract][Full Text] [Related]
40. Upregulated miR-132 in Lgr5
Zhang L; Guo X; Zhang D; Fan Y; Qin L; Dong S; Zhang L
Mol Carcinog; 2017 Sep; 56(9):2022-2034. PubMed ID: 28383763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
